American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of germline alterations in appendiceal adenocarcinoma
    Journal Article

    Foote, M. B.; Walch, H.; Kemel, Y.; Vakiani, E.; Johannet, P.; Sheehan, M.; Chatila, W.; Chung, S.; Nash, G. M.; Maio, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma
    Journal Article

    Blandin, A. F.; Giglio, R.; Graham, M. S.; Garcia, G.; Malinowski, S.; Woods, J. K.; Ramkissoon, S.; Ramkissoon, L.; Dubois, F.; Schoolcraft, K.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Cytochrome P450 oxidoreductase (POR) associated with severe paclitaxel-induced peripheral neuropathy in patients of European ancestry from ECOG-ACRIN E5103
    Journal Article

    Shen, F.; Jiang, G.; Philips, S.; Gardner, L.; Xue, G.; Cantor, E.; Ly, R. C.; Osei, W.; Wu, X.; Dang, C.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Plasma 25-hydroxyvitamin D levels and survival in stage III colon cancer: Findings from CALGB/SWOG 80702 (Alliance)
    Journal Article

    Wang, Q. L.; Ma, C.; Yuan, C.; Shi, Q.; Wolpin, B. M.; Zhang, Y.; Fuchs, C. S.; Meyer, J.; Zemla, T.; Cheng, E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Expression and therapeutic targeting of TROP-2 in treatment-resistant prostate cancer
    Journal Article

    Sperger, J. M.; Helzer, K. T.; Stahlfeld, C. N.; Jiang, D.; Singh, A.; Kaufmann, K. R.; Niles, D. J.; Heninger, E.; Rydzewski, N. R.; Wang, L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • CD16(+) macrophages: An emerging biomarker for combined CTLA-4 and PD-1 blockade
    Editorial

    Smithy, J. W.; Luke, J. J.
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Overcoming barriers to tumor genomic profiling through direct-to-patient outreach
    Journal Article

    Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Project confirm: Accelerated drug approvals for chronic myeloid leukemia
    Editorial

    Sweet, K. L.; Cortes, J. E.; Apperley, J. F.; Mann, M.; Mauro, M. J.; Oehler, V. G.; Ruiz, C.; Schiffer, C. A.; Ehrlich, L. A.; Pamuk, G. E.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Eganelisib, a first-in-class PI3Kγ inhibitor, in patients with advanced solid tumors: Results of the phase 1/1b MARIO-1 trial
    Journal Article

    Hong, D. S.; Postow, M.; Chmielowski, B.; Sullivan, R.; Patnaik, A.; Cohen, E. E. W.; Shapiro, G.; Steuer, C.; Gutierrez, M.; Yeckes-Rodin, H.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Myosin light-chain kinase inhibition potentiates the antitumor effects of avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor
    Journal Article

    Rossi, F.; Liu, M.; Tieniber, A.; Etherington, M. S.; Hanna, A.; Vitiello, G. A.; Param, N. J.; Do, K.; Wang, L.; Antonescu, C. R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: